4//SEC Filing
Sibold William John 4
Accession 0001628280-25-009091
CIK 0001157601other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:36 PM ET
Size
8.0 KB
Accession
0001628280-25-009091
Insider Transaction Report
Form 4
Sibold William John
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Performance Restricted Stock Units
2025-02-27−50,000→ 0 total→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2025-02-27+50,000→ 104,303 total
Footnotes (2)
- [F1]On February 27, 2025, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 2. Although the Issuer is irrevocably obligated to issue these shares to the Reporting Person, these shares will settle and be delivered to the Reporting Person on September 8, 2027, the fourth anniversary of the commencement of his employment with the Issuer.
- [F2]On September 11, 2023, the Reporting Person was granted a one-time sign-on award of performance-based restricted stock units (PSUs) with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award and is eligible to earn up to an additional 100,000 shares upon the achievement of sustained stock price appreciation hurdles. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the PSUs.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0001518611
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:36 PM ET
- Size
- 8.0 KB